Familial Congenital Hypothyroidism due to Compound Heterozygous Variants in the TPO Gene: Neonatal Diagnosis, Phenotypic Variability, and Lessons From Long‐Term Follow‐Up in Three Brothers
Jan 2026· Case Reports in Genetics· Vol 2026· 0 citations· 13 references
Medicine
TL;DR
Together, these three cases show that the prognosis of treated neonatal CH depends as much on the quality of postdiagnosis monitoring as on how quickly the initial diagnosis is made, and make the case for systematic family thyroid screening once a sibling is known to carry dyshormonogenetic CH.
Abstract
Dyshormonogenesis accounts for 15%–20% of permanent congenital hypothyroidism (CH), and pathogenic variants in the thyroid peroxidase (TPO) gene are its most frequent cause. We report three brothers, all diagnosed with severe CH in the neonatal period and referred to our Medical Genetics Unit in 2021 for molecular characterization and genetic counseling. Whole‐exome sequencing, followed by a targeted thyroid gene panel, identified the same compound heterozygous TPO genotype in all three: NM_000547.6:c.1297G > A, p.(Val433Met), inherited from the carrier mother, and NM_000547.6:c.1964G > C, p.(Cys655Ser), inherited from the carrier father, confirming autosomal recessive dyshormonogenetic CH. At neonatal diagnosis, initial TSH exceeded 100 mIU/L in all three brothers (reference range approximately 1–20 mIU/L beyond the first days of life (Wassner 2018 and Léger et al. 2014)). Despite this identical genetic cause and comparable neonatal severity, the three brothers (hereafter Patient 1, Patient 2, and Patient 3, the index case) went on to show markedly divergent clinical trajectories. Patient 1 was treated continuously from birth. Patient 2 was correctly identified neonatally through a proactive family thyroid screening, prompted by his elder brother’s pre‐existing diagnosis, but was then lost to adequate endocrine follow‐up: his levothyroxine dose stayed static and unadjusted for several years while his TSH remained persistently elevated. Patient 3, the index case, was diagnosed at Day 3 through Guthrie neonatal screening, and it was his diagnosis that prompted the family‐wide reassessment which ultimately confirmed the genotype in all three brothers. He additionally carries a heterozygous SLC26A4 variant of uncertain significance. Together, these three cases show that the prognosis of treated neonatal CH depends as much on the quality of postdiagnosis monitoring as on how quickly the initial diagnosis is made. They also make the case for systematic family thyroid screening once a sibling is known to carry dyshormonogenetic CH, and for the value molecular diagnosis adds to parental counseling and reproductive planning.
Background: Recurrent fetal loss can arise from a wide range of genetic abnormalities, many of which remain undetected in the absence of comprehensive molecular testing. Trio-based clinical exome sequencing enables the systematic identification of candidate mutations and variants of uncertain significance (VUS) that un...
G. Padmavathi, A. Munirajan, Ravi Sudesh et al.· Journal of Biochemical and C...· 0 citations
Gitelman syndrome (GS) is an autosomal recessive renal tubulopathy caused by loss-of-function mutations in the
SLC12A3
gene, which encodes the thiazide-sensitive sodium-chloride cotransporter (NCC). Diagnosis can be challenging due to clinical and genetic heterogeneity, and novel variants of uncertain significanc...
Zhong-Ren Shen, Xiao-Qun Liu, Zong-Rui Shen et al.· Orphanet Journal of Rare Dis...· 0 citations
Congenital Anomalies of the Kidney and Urinary Tract with or without Hearing Loss, Abnormal Ears, or Developmental Delay (CAKUTHED) is an autosomal dominant syndromic form of congenital anomalies of the kidney and urinary tract associated with heterozygous pathogenic variants in
PBX1
. The disorder is character...
Wen-Qi Chen, Yan-Xin Meng, Ke Hu et al.· Frontiers in Genetics· 0 citations
A retrospective analysis of a Chinese boy with suspected SCKL5 found two novel CEP152 variants, c.3661delA and c.1577+3A>G, which expand the variant and phenotypic spectrum of CEP152 and provide valuable insights for genetic counseling.
M. Du, Peng-Chao Wang, Zi-Qin Liu et al.· Genes· 0 citations
Gene mutations in the SURF1 gene are linked to mitochondrial disorders that can cause severe neurodegenerative diseases in early childhood. Rarely, mutations in this gene are also associated with Charcot-Marie-Tooth disease type 4K (CMT4K), a hereditary neuropathy that leads to progressive motor decline. Here, a case o...
Jayveersinh A. Makwana, S. Pajai· Journal of Clinical and Diag...· 0 citations
Thyroid dysgenesis (TD) is the main cause of congenital hypothyroidism (CH). However, a definitive genetic cause is confirmed in only 2-5% of patients, since pathogenic mutations are rare. This study was conducted to advance the understanding of TD genetic basis by investigating genetic alterations in the exomes of aff...
E. Brust, Gustavo Felisola Caso, Rodrigo Cesar de Sá Suetsugu et al.· Molecular and Cellular Endoc...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.